首页 › 股票 › FRLN

FRLN — FREELINE THERAPEUTICS HLDGS

申报持仓市值$17.87M
持有基金数(最新)24
板块—

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

HoldingsHub 追踪了 FRLN(FREELINE THERAPEUTICS HLDGS)近五年的季度 13F 申报数据。历史上有 24 家基金申报过持仓,其最近一期申报市值合计 $17.87M。最新季度无机构披露持仓,通常意味着该股已退出追踪基金的组合,而非不可投资。

FREELINE THERAPEUTICS HLDGS(FRLN)的主要机构持有人包括 Syncona Portfolio Ltd、MILLENNIUM MANAGEMENT LLC、Millennium Management,按 13F 申报市值在本页 24 家持有人中排名居前。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q4 2023 15 1.93M $12.37M +5.1%
Q3 2023 12 2.61M $11.07M +12.2%
Q2 2023 4 105.71K $272.34K -90.2%
Q1 2023 6 1.24M $492.10K +24.4%
Q4 2022 6 998.63K $464.62K -0.6%
Q3 2022 4 954.25K $668.00K -7.4%
Q2 2022 4 1.03M $897.00K -18.8%
Q1 2022 6 1.27M $1.42M +113.6%

表内 8 个季度中,机构持股合计增加 52%(Q1 2022 → Q4 2023);单季变动最大的是 Q1 2022(+113.6%)。

前 25 大机构持仓人(Q4 2023) — 15 家基金

基金股数金额组合权重变化
Syncona Portfolio Ltd 1.47M $9.33M 5.91% 持有
UBS Group AG 99.36K $632.91K 0.00% 增持
Blue Owl Capital Holdings LP 86.65K $551.99K 0.13% 新进
PenderFund Capital Management Ltd. 60.40K $509.02K 0.17% 新进
JPMorgan Chase & Co 67.05K $426.46K 0.00% 新进
Morgan Stanley 42.76K $272.36K 0.00% 增持
Renaissance Technologies 34.46K $220.00K 0.00% 增持
HARBOR CAPITAL ADVISORS, INC. 20.35K $129.44K 0.03% 增持
SPHERA FUNDS MANAGEMENT LTD. 16.45K $104.75K 0.02% 新进
Northern Trust Corp 15.66K $99.75K 0.00% 持有
49 WEALTH MANAGEMENT, LLC 15.52K $98.86K 0.03% 新进
RHUMBLINE ADVISERS 155 $985 0.00% 增持
Gradient Investments LLC 100 $637 0.00% 新进
Aspire Private Capital, LLC 80 $509 0.00% 持有
Qube Research & Technologies Ltd 4 $25 0.00% 持有

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q3 2023 — 12 家基金

基金股数金额组合权重变化
Syncona Portfolio Ltd 1.47M $6.22M 9.26% 新进
MILLENNIUM MANAGEMENT LLC 370.54K $1.57M 0.00% 新进
Millennium Management 370.54K $1.57M 0.00% 新进
Tetragon Partners GP Ltd 266.67K $1.15M 0.28% 新进
Morgan Stanley 42.43K $182.47K 0.00% 增持
UBS Group AG 34.20K $147.08K 0.00% 增持
Renaissance Technologies 26.36K $113.00K 0.00% 增持
Northern Trust Corp 15.66K $67.33K 0.00% 持有
HARBOR CAPITAL ADVISORS, INC. 12.50K $53.02K 0.01% 新进
RHUMBLINE ADVISERS 115 $487 0.00% 新进
Aspire Private Capital, LLC 80 $344 0.00% 新进
Qube Research & Technologies Ltd 4 $17 0.00% 新进

Q2 2023 — 4 家基金

基金股数金额组合权重变化
Morgan Stanley 34.86K $89.94K 0.00% 减持
UBS Group AG 33.33K $86.00K 0.00% 减持
Renaissance Technologies 21.86K $56.00K 0.00% 减持
Northern Trust Corp 15.66K $40.40K 0.00% 新进

Q1 2023 — 6 家基金

基金股数金额组合权重变化
UBS Group AG 500.00K $227.50K 0.00% 减持
Renaissance Technologies 230.60K $105.00K 0.00% 增持
Morgan Stanley 189.50K $86.23K 0.00% 减持
Citadel Advisors 116.80K $53.73K 0.00% 增持
Two Sigma Investments 43.01K $19.57K 0.00% 减持
Millennium Management 162.21K $75 0.00% 增持

Q4 2022 — 6 家基金

基金股数金额组合权重变化
UBS Group AG 516.93K $248.12K 0.00% 持有
Renaissance Technologies 196.39K $93.00K 0.00% 减持
Morgan Stanley 191.40K $90.94K 0.00% 增持
Two Sigma Investments 43.60K $20.72K 0.00% 减持
Citadel Advisors 23.76K $11.83K 0.00% 新进
Millennium Management 26.54K $13 0.00% 新进

Q3 2022 — 4 家基金

基金股数金额组合权重变化
UBS Group AG 516.20K $361.00K 0.00% 增持
Renaissance Technologies 214.00K $150.00K 0.00% 减持
Morgan Stanley 173.15K $121.00K 0.00% 减持
Two Sigma Investments 50.91K $36.00K 0.00% 减持

新建仓(最新)

本季度没有基金新建该仓位。

完全清仓(较上季)

本季度没有被追踪基金完全清仓。

基金持仓历史 — 各季度股数(前 20 只基金)

基金Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020
Syncona Portfolio Ltd 1.47M 1.47M — — — — — — — — — — —
UBS Group AG 99.36K 34.20K 33.33K 500.00K 516.93K 516.20K 504.54K 504.71K — 500 — — —
Blue Owl Capital Holdings LP 86.65K — — — — — — — — — — — —
PenderFund Capital Management Ltd. 60.40K — — — — — — — — — — — —
JPMorgan Chase & Co 67.05K — — — — — — 664 — — — — —
Morgan Stanley 42.76K 42.43K 34.86K 189.50K 191.40K 173.15K 192.94K 184.73K 106.53K 41.34K — — —
Renaissance Technologies 34.46K 26.36K 21.86K 230.60K 196.39K 214.00K 265.22K 446.41K 210.10K 194.50K — — —
HARBOR CAPITAL ADVISORS, INC. 20.35K 12.50K — — — — — — — — — — —
SPHERA FUNDS MANAGEMENT LTD. 16.45K — — — — — — — — — — — —
Northern Trust Corp 15.66K 15.66K 15.66K — — — — — — — — — —
49 WEALTH MANAGEMENT, LLC 15.52K — — — — — — — — — — — —
RHUMBLINE ADVISERS 155 115 — — — — — — — — — — —
Gradient Investments LLC 100 — — — — — — — — — — — —
Aspire Private Capital, LLC 80 80 — — — — — — — — — — —
Qube Research & Technologies Ltd 4 4 — — — — — — — — — — —
MILLENNIUM MANAGEMENT LLC — 370.54K — — — — — — — — — — —
Tetragon Partners GP Ltd — 266.67K — — — — — — — — — — —
Legal & General Investment Management America — — — — — — — — — 15.04K 15.04K 13.08K 13.08K
Citigroup Inc — — — — — — — 347 — — — — —
Marshall Wace — — — — — — — — 110.69K 356.13K — — —

下载持有人名单 (CSV)

常见问题

Which funds hold FRLN?

24 funds have reported positions in FRLN across five years of 13F filings; the sum of their latest reported stakes is $17.87M.

Who are the top institutional holders of FRLN?

The largest 13F holders are Syncona Portfolio Ltd, MILLENNIUM MANAGEMENT LLC, Millennium Management, Tetragon Partners GP Ltd, Wellington Management Group; the top 25 are ranked at the top of this page.

Who are the major shareholders of FREELINE THERAPEUTICS HLDGS?

The major shareholders of FREELINE THERAPEUTICS HLDGS (FRLN) by reported 13F value are Syncona Portfolio Ltd, MILLENNIUM MANAGEMENT LLC, Millennium Management, Tetragon Partners GP Ltd, Wellington Management Group, among 24 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 FRLN」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/FRLN/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →